These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11085324)

  • 1. Pharmacology of MDMA in humans.
    de la Torre R ; Farré M; Roset PN; Lopez CH; Mas M; Ortuño J; Menoyo E; Pizarro N; Segura J; Cami J
    Ann N Y Acad Sci; 2000 Sep; 914():225-37. PubMed ID: 11085324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Pharmacology of Mephedrone in Comparison with MDMA.
    Papaseit E; Pérez-Mañá C; Mateus JA; Pujadas M; Fonseca F; Torrens M; Olesti E; de la Torre R; Farré M
    Neuropsychopharmacology; 2016 Oct; 41(11):2704-13. PubMed ID: 27206266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans.
    Mas M; Farré M; de la Torre R; Roset PN; Ortuño J; Segura J; Camí J
    J Pharmacol Exp Ther; 1999 Jul; 290(1):136-45. PubMed ID: 10381769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.
    Harris DS; Baggott M; Mendelson JH; Mendelson JE; Jones RT
    Psychopharmacology (Berl); 2002 Aug; 162(4):396-405. PubMed ID: 12172693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 4 h apart Human pharmacology of MDMA after repeated doses taken 4 h apart.
    Farré M; Tomillero A; Pérez-Mañá C; Yubero S; Papaseit E; Roset PN; Pujadas M; Torrens M; Camí J; de la Torre R
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1637-49. PubMed ID: 26073279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart.
    Peiró AM; Farré M; Roset PN; Carbó M; Pujadas M; Torrens M; Camí J; de la Torre R
    Psychopharmacology (Berl); 2013 Feb; 225(4):883-93. PubMed ID: 23142957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics.
    Farré M; Abanades S; Roset PN; Peiró AM; Torrens M; O'Mathúna B; Segura M; de la Torre R
    J Pharmacol Exp Ther; 2007 Dec; 323(3):954-62. PubMed ID: 17890444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration.
    Kolbrich EA; Goodwin RS; Gorelick DA; Hayes RJ; Stein EA; Huestis MA
    J Clin Psychopharmacol; 2008 Aug; 28(4):432-40. PubMed ID: 18626271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects.
    Cami J; Farré M; Mas M; Roset PN; Poudevida S; Mas A; San L; de la Torre R
    J Clin Psychopharmacol; 2000 Aug; 20(4):455-66. PubMed ID: 10917407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety pharmacology of acute MDMA administration in healthy subjects.
    Vizeli P; Liechti ME
    J Psychopharmacol; 2017 May; 31(5):576-588. PubMed ID: 28443695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanol co-administration moderates 3,4-methylenedioxymethamphetamine effects on human physiology.
    Dumont GJ; Kramers C; Sweep FC; Willemsen JJ; Touw DJ; Schoemaker RC; van Gerven JM; Buitelaar JK; Verkes RJ
    J Psychopharmacol; 2010 Feb; 24(2):165-74. PubMed ID: 19074534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in the subjective effects of MDMA.
    Liechti ME; Gamma A; Vollenweider FX
    Psychopharmacology (Berl); 2001 Mar; 154(2):161-8. PubMed ID: 11314678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.
    Tancer M; Johanson CE
    Psychopharmacology (Berl); 2007 Jan; 189(4):565-73. PubMed ID: 17047932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute psychomotor effects of MDMA and ethanol (co-) administration over time in healthy volunteers.
    Dumont GJ; Schoemaker RC; Touw DJ; Sweep FC; Buitelaar JK; van Gerven JM; Verkes RJ
    J Psychopharmacol; 2010 Feb; 24(2):155-64. PubMed ID: 19164498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers.
    Liechti ME; Vollenweider FX
    J Psychopharmacol; 2000; 14(3):269-74. PubMed ID: 11106307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDMA affects both error-rate dependent and independent aspects of decision-making in a two-choice prediction task.
    Vollenweider FX; Liechti ME; Paulus MP
    J Psychopharmacol; 2005 Jul; 19(4):366-74. PubMed ID: 15982991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans.
    Liechti ME; Vollenweider FX
    Eur Neuropsychopharmacol; 2000 Jul; 10(4):289-95. PubMed ID: 10871712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers.
    Vollenweider FX; Gamma A; Liechti M; Huber T
    Neuropsychopharmacology; 1998 Oct; 19(4):241-51. PubMed ID: 9718588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics.
    Hernández-López C; Farré M; Roset PN; Menoyo E; Pizarro N; Ortuño J; Torrens M; Camí J; de La Torre R
    J Pharmacol Exp Ther; 2002 Jan; 300(1):236-44. PubMed ID: 11752122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function.
    Kuypers KP; Samyn N; Ramaekers JG
    Psychopharmacology (Berl); 2006 Sep; 187(4):467-75. PubMed ID: 16830130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.